ThromboGenics Appoints Thomas Clay as New Board Member
ThromboGenics NV announced that Thomas Clay has been appointed as a non-executive director with immediate effect.
Thomas Clay (26) is Vice-President of East Hill Management Company, a US-based venture capital firm specializing in the lifescience sector. He is also a director of Golden Queen Mining Company Ltd., a development-stage gold mining company, and the Clay Mathematics Institute. Thomas has an AB degree from Harvard University in Classics and a Masters degree from Oxford University in Greek and Latin Languages and Literatures. Thomas replaces his father Landon Clay, who has resigned from the Board.
In addition, the Board will propose the nomination of Patricia Ceysens (46), a Flemish politician, as non-executive director at ThromboGenics’ 2012 Annual Shareholder Meeting. Mrs. Ceysens was the Flemish minister of Economy, Foreign Policy and Foreign Trade from 2003 to 2004, and Flemish minister of Economics, Business, science, Innovation and Foreign Trade from 2007 to 2009. She studied law at the Catholic University of Leuven.
Most read news
Other news from the department people
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.